Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease

• Published in: International journal of cardiology Vol. 222; pp. 113 - 118
• Main Authors: Nishiyama, Naoki, Komatsu, Takaaki, Kuroyanagi, Takanori, Fujikake, Akinori, Komatsu, Sachiko, Nakamura, Hidehiko, Yamada, Kota, Nakahara, Shiro, Kobayashi, Sayuki, Taguchi, Isao
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.11.2016
• Subjects: Aged; Angioplasty, Balloon, Coronary - adverse effects; Angioplasty, Balloon, Coronary - instrumentation; Angioplasty, Balloon, Coronary - methods; Antineoplastic Agents, Phytogenic - therapeutic use; Cardiovascular; Coronary Angiography - methods; Coronary Artery Disease - diagnosis; Coronary Artery Disease - physiopathology; Coronary Artery Disease - surgery; Coronary Restenosis - diagnosis; Coronary Restenosis - etiology; Coronary Restenosis - prevention & control; Coronary Vessels - diagnostic imaging; Drug-coated balloon; Drug-eluting stent; Drug-Eluting Stents - adverse effects; Female; Humans; Male; Middle Aged; Paclitaxel - therapeutic use; Restenosis; Treatment Outcome; ‘Stent-less’ percutaneous coronary intervention; restenosis; drug-eluting stent; drug-coated balloon; ‘stent-less’ percutaneous coronary intervention; Drug-coated balloon; Restenosis; ‘Stent-less’ percutaneous coronary intervention; Drug-eluting stent

Abstract Background Despite the low restenosis rates of drug-eluting stents (DES), several problems remain, including stent thrombosis, stent fracture, and neo-atherosclerosis. ‘Stent-less’ (balloon alone) percutaneous coronary intervention (PCI) is still being used, and several clinical trials have...